Clinical Trial Update: Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing transcoronary infusion of cardiac progenitor cells in pediatric dilated cardiomyopathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• Cardiac progenitor cells (transcoronary infusion)

Snippet

Sponsor: Okayama University | Conditions: Dilated Cardiomyopathy | Phase 1 | Status: COMPLETED | Results posted: 2021-11-01